Page 41 - JSOM Fall 2018
P. 41

Worldwide Case Reports
                             Using the iTClamp for External Hemorrhage Control




                                                                                              1,2
                              Jessica L. Mckee, BA, MSc *; Andrew W. Kirkpatrick, MD, FRCSC ;
                                                        1
                                                           4
                    Brad L. Bennett, PhD ; Don Jenkins, MD ; Sarvesh Logsetty, MD ;John B. Holcomb, MD    6
                                         3
                                                                                  5


              ABSTRACT
              Background: Historically, hemorrhage control strategies con­  also a major challenge and carry a mortality rate of 10% to
              sisted of manual pressure, pressure dressings, gauze with or   50%  with bleeding from major vascular injuries accounting
                                                                    9
              without hemostatic ingredients for wound packing, or the use   for 50% of the deaths. 10
              of tourniquets. The iTClamp is a relatively new alternative to
              stop external bleeding. Methods: An anonymous survey was   Effective hemorrhage control methods for scalp and neck
              used to evaluate the outcomes of the iTClamp in worldwide   wounds are limited. Research has also demonstrated a posi­
              cases of external bleeding. Results: A total of 245 evaluable   tive correlation between prehospital response time and mor­
              applications were reported. The iTClamp stopped the bleeding   tality, particularly with penetrating injury, specifically gunshot
              in 81% (n = 198) of the cases. Inadequate bleeding control   wounds and stabbings.  Therefore, with the number of poten­
                                                                                  11
              was documented in 8% (n = 20) and in the remaining 11%    tial wounds that will need treatment and the qualifier that in
              (n = 27), bleeding control was not reported. The top three an­  cases of hemorrhage the “scoop and run” mentality may save
                                                                     11
              atomic body regions for iTClamp application were the scalp,   lives,  a device that can save time and is hands­free but still
              37% (n = 91); arm, 20% (n = 49); and leg, 19% (n = 46). In   safe and effective, even with less demanding wounds, can al­
              26% of the reported cases (direct pressure [23% (n = 63)] and   leviate the gap in prehospital hemorrhage control and wound
              tourniquets [3% (n = 8]), other techniques were abandoned   care, particularly in anatomic regions where a tourniquet can­
              in favor of the iTClamp. Conversely, the iTClamp was aban­  not be applied.
              doned in favor of direct pressure 11 times (4.4%) and aban­
              doned in favor of a tourniquet three times (1%). Conclusion:   Postmarket surveillance is a tool used to ensure the safety of
              The iTClamp appears to be a fast and reliable device to stop   pharmaceutical drugs and medical devices after they have been
              external bleeding. Because of its function and possible applica­  released to the market. There are several modalities for post­
              tions, it has potential to lessen the gap between and add to the   market surveillance, including, but not limited to, spontaneous
              present selection of devices for treatment of external bleeding.  reporting databases. Postmarket surveillance is required at the
                                                                 company level by the European Medicines Agency (EMA) and
              Keywords:  trauma; bleeding control; emergency medical   can be required by the Food and Drug Administration (FDA) for
              service; iTClamp                                   certain class II and class III medical devices. Health Canada (HC)
                                                                 does not require formal postmarket surveillance at the company
                                                                 level; however, all reportable incidents must be reported to HC.
              Introduction                                       Data collected at the company level for postmarket surveillance
                                                                 are collected very stringently. This information helps inform the
              It is well understood that bleeding is the leading cause of pre­  risk­benefit management of each product and can lead to prod­
              ventable death in traumatic injuries of all types ; however, fur­  uct warnings, labelling changes, and even product recalls. Com­
                                                  1
              ther examination of this issue reveals that the epidemiology of   panies face severe governmental agency (i.e., EMA, FDA, and
              wounds in general, not just life­endangering wounds, is signif­  HC) castigation for not reporting adverse events.
              icant. In 2005, nearly 12 million wounds were treated in the
              hospital  emergency  departments,  of which  7.3 million  were   One such medical device approved by HC, FDA, and EMA is
              lacerations.  An additional 2 million people were treated as   the iTClamp (Innovative Trauma Care [iTraumaCare], https://
                       2
              outpatients for a cutting or piercing incident,  nearly 5 million   www.innovativetraumacare.com). The iTClamp quickly con­
                                                2
              animal bites were treated,  and 1.5 million skin tears in the   trols critical bleeding by closing the skin to create a temporary,
                                  3
              elderly occur annually.  Brookes et al  reported that nearly half   contained hematoma until surgical repair. The iTClamp is a
                                          5
                               4
              of all civilian trauma incidents include a scalp laceration, an   self­locking trauma clamp with eight needles. These needles
              anatomic region where hemorrhage is a challenge to control   penetrate  the  skin to  evert  the  skin edges  between  pressure
              and where missed or uncontrolled injury can result in hypo­  bars of the device and anchor the device to the skin to reduce
              tension, shock, and even death.  Penetrating neck injuries are   slippage and leakage. Pressure is evenly distributed across
                                      6–8
              *Correspondence to Jessica.Mckee@ualberta.ca
              1 Ms Mckee and Dr Kirkpatrick are at University of Calgary, Calgary, Alberta, Canada;  Dr Kirkpatrick is at Regional Trauma Services, University
                                                                         2
              of Calgary;  Dr Bennett is at Military & Emergency Medicine Dept, F. Edward Hébert School of Medicine, Uniformed Services University of the
                      3
                                        4
              Health Sciences, Bethesda Maryland;  Dr Jenkins is at Department of Surgery, Division of Trauma and Emergency General Surgery, University
                                                  5
              of Texas Health Science Center, San Antonio, Texas;  Dr Logsetty is at Department of Surgery, Max Rady College of Medicine, Rady Faculty of
                                               6
              Health Sciences, Winnipeg, Manitoba, Canada;  Dr Holcomb is at Department of Surgery, Division of Acute Care Surgery at The University of
              Texas Health Science Center.
                                                              39
   36   37   38   39   40   41   42   43   44   45   46